Zymeworks to present clinical data on cancer drug candidates at AACR

March 17, 2026 5:02 PM

Zymeworks Inc. (NASDAQ: ZYME) will present clinical and preclinical data on its antibody-drug conjugate programs at the American Association for ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found